Asset
ASAPIPRANT
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05152641 | phase2 | withdrawn | 2022-04-01 | 2023-04-01 | BioAge Labs, Inc. | Study to Evaluate Efficacy and Safety of BGE-117 in Moderately to Severely Anemic Older Individuals After Major Hip Surgery |
| NCT04705597 | phase2 | terminated | 2021-03-18 | 2022-04-20 | BioAge Labs, Inc. | Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure |
FDA applications (0)
This company has no applications containing this asset.